Neurocrine Biosciences Inc
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 19,030 | 0.0% | 134,172 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 19,225 | 0.0% | 136,950 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 17,008 | 0.0% | 135,314 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 15,146 | 0.0% | 136,944 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 18,639 | 0.0% | 136,549 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 15,458 | 0.0% | 134,160 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 18,972 | 0.0% | 137,805 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 19,916 | 0.0% | 144,405 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 19,070 | 0.0% | 144,731 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 16,386 | 0.0% | 145,651 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 14,399 | 0.0% | 152,689 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 15,935 | 0.0% | 157,431 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 18,872 | 0.0% | 158,004 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 16,520 | 0.0% | 155,537 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 15,317 | 0.0% | 157,126 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 14,641 | 0.0% | 156,173 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 14,112 | 0.0% | 165,688 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 15,731 | 0.0% | 164,014 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 16,330 | 0.0% | 167,794 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 17,033 | 0.0% | 175,150 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 16,574 | 0.0% | 172,914 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 16,201 | 0.0% | 168,482 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 20,075 | 0.0% | 164,547 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 13,566 | 0.0% | 156,744 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 17,101 | 0.0% | 159,094 | 12/31/2019 |
| 2014 Q1 | 5/8/2014 | 2,207 | 0.0% | 137,102 | 3/31/2014 |
| 2013 Q4 | 2/10/2014 | 1,128 | 0.0% | 120,802 | 12/31/2013 |